Imaging3, Inc. to Open Exhibit at Radiological Society of North America (RSNA) 2011
Published: Nov 28, 2011
CHICAGO, IL--(Marketwire - November 28, 2011) -
"This is our eighth year exhibiting at RSNA and we anticipate a successful conference and the opportunity to present the significant progress we have made in the DViS technology platform over the last year. In addition to new and more advanced imaging, attendees of the conference will be able to view DViS generated images," commented Mr. Dean Janes, CEO of Imaging3, Inc. Imaging3 is in Booth 5829 in the South Hall of McCormick Place adjacent to the Toshiba and Hologic Booths.
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.